ZYMENEX
LIVE

Serial Number

79138261

Owner

Zymenex A/S

Attorney

Mary A. Donovan

Filing Date

Sep 27, 2013

Add to watchlist:

No watchlists yet
View on USPTO

ZYMENEX Trademark

Serial Number: 79138261 • Registration: 4774616

ZYMENEX is a trademark filed by Zymenex A/S on September 27, 2013. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

Zymenex A/S (8 trademarks)

Roskildevej 12C

Entity Type: 16

Trademark Details

Filing Date

September 27, 2013

Registration Date

July 21, 2015

Published for Opposition

May 5, 2015

Cancellation Date

May 23, 2025

Goods & Services

Surgical and medical apparatus and instruments, namely, syringes and needles for medical purposes, inhalers and blood testing apparatus for use in the treatment of porphyria illness, lysosomal enzyme deficiency diseases, non-bacterial diseases and other diseases related thereto

Computer software for use in database management in the fields of medicine, education and retail sales; website development software; communications software for connecting computer network users and global computer networks; downloadable electronic publications in the nature of books, magazines, periodicals and manuals in the field of medicine; electronic publications, namely, books, magazines, periodicals and manuals in the field of medicine, recorded on CD-ROMs and disks; and data processors

Providing education in the nature of seminars, training courses and instruction in the fields of medicine and information technology (IT)

Providing medical information via the Internet; providing advice regarding personal management of medical conditions; providing advice to health professionals regarding medical conditions; providing medical information and medical counseling

Pharmaceutical preparations and substances, only available by a physician's prescription for medical purposes used in the field of human illnesses or deficiencies, namely, enzyme deficiency diseases including alpha-mannosidosis, galactocerebrosid-galactosidase including Krabbe Disease, and aspartylglucosaminidase to treat Aspartylglucosaminuria, porphobilinogen deaminase to treat porphyria illness including Acute Intermittent Porphyria and other diseases related thereto, none of the foregoing being enzyme preparations for dietary purposes; enzymes, enzyme-inhibitors, enzyme co-factors and enzyme related preparations, only available by a physician's prescription, all for medical purposes for the treatment of human illnesses or deficiencies, namely, enzyme deficiency diseases including alpha-mannosidosis, galactocerebrosid-galactosidase including Krabbe Disease, and aspartylglucosaminidase to treat Aspartylglucosaminuria, porphobilinogen deaminase to treat porphyria illness including Acute Intermittent Porphyria and other diseases related thereto, none of the foregoing being enzyme preparations for dietary purposes; diagnostic preparations only available by a physician's prescription for medical purposes used in the field of human illnesses or deficiencies, namely, enzyme deficiency diseases including alpha-mannosidosis, galactocerebrosid-galactosidase including Krabbe Disease, and aspartylglucosaminidase to treat Aspartylglucosaminuria, porphobilinogen deaminase to treat porphyria illness including Acute Intermittent Porphyria and other diseases related thereto, none of the foregoing being enzyme preparations for dietary purposes

Scientific, industrial, biotechnological and biomedical research in the field of human illnesses or deficiencies, namely, porphyria illness, lysosomal enzyme deficiency diseases, non-bacterial diseases and other diseases related thereto and research concerning the medical treatment thereof; computer services, namely, providing a database featuring data concerning medical analysis and treatment, all for research purposes; designing, implementing and maintaining websites for others; computer network design and installation of computer software

Publications, namely, books, magazines, printed periodicals and manuals in the fields of medicine and health; printed instructional or teaching matter in the fields of medicine and health; printed instructional material and printed treatment guides in the field of medicine and health issues; manuals concerning the installation and maintenance of computer software

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Feb 12, 2026 DENA
DEATH OF INTERNATIONAL REGISTRATION
Feb 12, 2026 DETH
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Dec 18, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Dec 18, 2025 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
May 30, 2023 FINT
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Apr 13, 2023 INNA
GENERIC MADRID TRANSACTION SENT TO IB
Apr 12, 2023 XXSS
GENERIC MADRID TRANSACTION CREATED
Apr 12, 2023 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 4, 2022 INTR
CANCELLED SECTION 71
Feb 4, 2022 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 21, 2020 REM3
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 13, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 13, 2018 REAP
NEW REPRESENTATIVE AT IB RECEIVED
Sep 8, 2017 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Apr 20, 2017 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 9, 2017 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 8, 2016 FINO
NEW REPRESENTATIVE AT IB RECEIVED
Dec 18, 2015 NREP
FINAL DISPOSITION NOTICE SENT TO IB
Dec 9, 2015 FICS
FINAL DISPOSITION PROCESSED
Dec 9, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 21, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 21, 2015 R.PR
INTERNATIONAL REGISTRATION RENEWED
Jun 11, 2015 RNWL
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 5, 2015 NPUB
PUBLISHED FOR OPPOSITION
May 5, 2015 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 24, 2015 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 15, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 15, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 15, 2015 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 8, 2015 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 8, 2015 OPNR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 31, 2015 PREV
ASSIGNED TO LIE
Mar 27, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 9, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 9, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 9, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 9, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 9, 2015 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 13, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 12, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 12, 2015 TROA
REFUSAL PROCESSED BY IB
Oct 3, 2014 RFNP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 14, 2014 GNRN
NON-FINAL ACTION E-MAILED
Aug 14, 2014 GNRT
NON-FINAL ACTION WRITTEN
Aug 14, 2014 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 22, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 21, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 21, 2014 TROA
REFUSAL PROCESSED BY IB
Feb 21, 2014 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 22, 2014 RFCS
REFUSAL PROCESSED BY MPU
Jan 22, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 21, 2014 RFCR
NON-FINAL ACTION WRITTEN
Jan 20, 2014 CNRT
ASSIGNED TO EXAMINER
Jan 13, 2014 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 19, 2013 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 13, 2013 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Nov 11, 2013 SDRC